Cox Antibodies

Santa Cruz Biotechnology features a diverse variety of Cox Antibodies for the detection and analysis of cyclooxygenases, key enzymes involved in the conversion of arachidonic acid to prostaglandins. Cox monoclonal antibodies support various research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cyclooxygenases, particularly COX-1 and COX-2, play essential roles in inflammation and pain signaling, making them important targets in the study of various diseases, including cancer, cardiovascular diseases, and inflammatory disorders. Understanding the expression and regulation of cyclooxygenases can provide insights into therapeutic strategies and the development of anti-inflammatory drugs. Cox monoclonal antibodies enable detailed investigation of cellular pathways and molecular mechanisms. Researchers can utilize Cox monoclonal antibodies to examine enzyme activity levels across different tissue types and experimental conditions. Advanced research techniques incorporating Cox monoclonal antibodies help reveal new aspects of disease progression and potential treatment approaches. Santa Cruz Biotechnology's Cox monoclonal antibodies support the scientific community in advancing understanding of inflammation and disease mechanisms.